Abstract
Ten percent of US patients with Lyme disease are coinfected with Babesia microti. A double-blind, placebo-controlled, crossover trial enrolled 25 patients with confirmed Borrelia burgdorferi/B microti coinfection, abnormal visual contrast sensitivity (VCS), and persistent symptoms despite prior treatment with atovaquone and azithromycin. Patients were randomly assigned to atovaquone suspension or placebo plus cholestyramine for 3 weeks, were crossed over for 3 weeks, and then received open-label atovaquone and cholestyramine for 6 weeks. Symptoms and VCS scores were recorded at baseline and after weeks 3, 6, 9, and 12. Improvements in symptoms and VCS deficits were observed only after at least 9 weeks of treatment. At week 12, 5 patients were asymptomatic, and 16 had a notable reduction in the number of symptoms. The entire cohort demonstrated significant increases in VCS scores. Adverse effects were rare. Patients coinfected with B burgdorferi and B microti derive measurable clinical benefit from prolonged treatment with atovaquone and cholestyramine. Longer-term combination therapy may be indicated.
References
Mar 11, 1991·The American Journal of Cardiology·W InsullM C Tsianco
Jul 1, 1983·Annals of Internal Medicine·A C SteereS E Malawista
Sep 13, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G P WormserB J Luft
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E D Shapiro, M A Gerber
Nov 18, 2000·The New England Journal of Medicine·P J KrauseA Spielman
Dec 13, 2000·International Journal for Parasitology·A M Kjemtrup, P A Conrad
May 8, 2001·Journal of Toxicology and Environmental Health. Part a·H K HudnellS Music
Jul 14, 2001·Antimicrobial Agents and Chemotherapy·C B KurtzJ D Klinger
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C ThompsonP J Krause
Oct 6, 2001·Gastroenterology Clinics of North America·L KyneC P Kelly
Jul 16, 2002·Current Opinion in Rheumatology·Arthur Weinstein, Michael Britchkov
Aug 2, 2002·Expert Opinion on Pharmacotherapy·Louis M Weiss
Jun 5, 2003·Expert Opinion on Investigational Drugs·Charles S Pavia
Jun 25, 2003·Neurology·Israel Steiner
Jun 25, 2003·Neurology·L B KruppB Chandler
Jul 2, 2003·Journal of the American Academy of Dermatology·Linda C WangShail Busbey
Feb 1, 2005·Neurotoxicology and Teratology·Ritchie C Shoemaker, Dennis E House
Citations
Apr 9, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul M LantosGary P Wormser
Jul 23, 2011·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Leonard H Sigal
Dec 31, 2019·PloS One·Kaitlin M YoungLisa A Waddell
May 19, 2021·Translational Vision Science & Technology·Alison W RebmanSheila K West